Daniel Sánchez‐Tejerina

584 citations
29 papers · 402 · 1 hit paper · h-index 8

Impact in

  • Neurology top 5%
    • Myasthenia Gravis and Thymoma
    • Long-Term Effects of COVID-19
    • Peripheral Neuropathies and Disorders
    • Amyotrophic Lateral Sclerosis Research
    • Autoimmune Neurological Disorders and Treatments

Papers in

Daniel Sánchez‐Tejerina

21 papers receiving 390 citations

Daniel Sánchez‐Tejerina's Hit Papers

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study 2023 · 188 citations
1880+1+2Years since publication50100150

Peers

Daniel Sánchez‐Tejerina
Comparison fields: 5 of 40
  • Neurology 296
  • Gastroenterology 7
  • Radiology, Nuclear Medicine and Imaging 21
  • Endocrinology, Diabetes and Metabolism 16
  • Pathology and Forensic Medicine 13
Replace Chiara Demichelis with:
Chiara Demichelis Italy
Masato Kadoya Japan
Ezequiel Agustin Piccione United States
Seok‐Jin Choi South Korea
Véronique Bissay Belgium
Erdita Peci Italy
Kensuke Hamada Japan
Marta Ruiz Italy
Alexander Carvajal-González United States
I Goto Japan
Daniel Sánchez‐Tejerina relative to Chiara Demichelis Italy Chiara Demichelis's profile →
Citations per field
00.5×2×4×5.3×
Chiara Demichelis · 1×
Citations per year

Countries citing papers authored by Daniel Sánchez‐Tejerina

Since Specialization
Citations

This map shows the geographic impact of Daniel Sánchez‐Tejerina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Sánchez‐Tejerina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Sánchez‐Tejerina more than expected).

Fields of papers citing papers by Daniel Sánchez‐Tejerina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Sánchez‐Tejerina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Sánchez‐Tejerina. The network helps show where Daniel Sánchez‐Tejerina may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Sánchez‐Tejerina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Sánchez‐Tejerina Line = papers co-authored together Daniel Sánchez‐Tejerina links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
Hit paper breakdown →
2023188
2 2020100
3 202222
4 202421
5 202210
6 202510
7 20239
8 20239
9 20237
10 20194
11 20233
12 20233
13 20243
14 20253
15 20222
16 20222
17 20222
18 20211
19 20211
20 20251

About Daniel Sánchez‐Tejerina

Daniel Sánchez‐Tejerina is a scholar working on Neurology, Clinical Biochemistry, Cellular and Molecular Neuroscience, Ophthalmology and Genetics, having authored 29 papers that have together received 402 indexed citations. Recurring topics across this work include Peripheral Neuropathies and Disorders (7 papers), Amyotrophic Lateral Sclerosis Research (4 papers), Genetic Neurodegenerative Diseases (3 papers), Myasthenia Gravis and Thymoma (3 papers), Genomics and Rare Diseases (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Hereditary Neurological Disorders (2 papers) and Mitochondrial Function and Pathology (2 papers). The work is most often cited by research in Neurology (296 citations), Gastroenterology (7 citations), Radiology, Nuclear Medicine and Imaging (21 citations), Endocrinology, Diabetes and Metabolism (16 citations) and Pathology and Forensic Medicine (13 citations). Daniel Sánchez‐Tejerina has collaborated with scholars based in Spain and United States. Frequent co-authors include Arnau Llauradó, Laura Bermejo‐Guerrero, Javier Sotoca, Jesús González de la Aleja, Julián Benito León, María Dolores Folgueira, María Salvadó, Raul Juntas Morales, Juan Luis Restrepo‐Vera and José Vidal. Their work appears in journals such as The Lancet Neurology, Acta Neurologica Scandinavica, Neurology, Brain and Behavior and Journal of the Neurological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact